0628 GMT February 25, 2020
The researchers hope that they can produce the drug career as medical supplementary for people who are at the risk of cancer genetically, ISNA wrote.
Sepideh Amjad, the lead author of the study said dendrimers are one of the drug-careers. “The drugs should be attached to the surface of dendrimers or be put inside their holes to send the drug.”
She said that biodegradability is one of the main characteristics of the drug-careers. “The anti-cancer drugs damage other tissues. We have been seeking design of drug-career dendrimers which can release anti-cancer drugs only in the intended point.”
Using the drug-career produced for prostate cancer treatment, the drug remains in blood and activates smartly especially for patients suffering cancer genetically.
She expressed the hope that the device could prove useful for people who are at the risk of cancer genetically.
The system does not release poison in body when released and is under in vitro tests.
Prostate cancer is the development of tumor in the prostate, a gland in the male reproductive system. It may initially cause no symptoms. In later stages, it can cause difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cells.